# Retinal Degeneration Conference

> **NIH NIH R13** · UNIVERSITY OF FLORIDA · 2022 · $1

## Abstract

Summary:
This application seeks funds to support the travel of young investigators to attend the Biennial International
Symposium on Retinal Degeneration (RD meeting) in the years 2020, 2022, and 2024. The meetings are
scheduled as satellite meetings of the Biennial Meeting of the International Society for Eye Research (ISER).
The location and timing of the RD meetings are coordinated with the location and timing of the ISER meeting.
The 2020 RD meeting has been named RD20/20 and will be held in Mendoza, Argentina on October 20th-25th,
and will be the 19th successive RD meeting. The locations of meetings in 2022 and 2024 will be in Asia and the
US respectively.
The Specific Aims of the RD meetings covered by this application are:
 1. To enhance the emerging careers of 20 Young Investigators (with equal representation by women and
 the inclusion of minorities) in retinal degeneration research by providing full travel support.
 2. To provide a platform to advance career development of Young Investigators.
 3. To provide a forum for dissemination of the most recent advances in the state of knowledge on the
 pathophysiologic mechanisms of acquired, inherited, and age-related retinal degenerations, and new
 therapeutic approaches to these diseases.
 4. To create an environment that will facilitate the exchange of novel ideas among basic and clinician
 scientists and generate the opportunity for vision scientists of all ethnic groups and social backgrounds
 to meet and establish research collaborations. The requested funds will only support the travel,
 accommodation, and registration fees for students, postdocs, fellows, and junior investigators who
 otherwise would not have the resources to attend these focused meetings.
The RD meetings have a 35-year history of scientific participation by leading retinal degeneration specialists
(basic scientists, clinician scientists, and more recently industry scientists), with a focus on macular
degeneration and inherited retinal degenerations that affect photoreceptors and the retinal pigment epithelium.
All presentations will include fresh, unpublished date covering the latest advances in the field. Topics typically
include the latest advances in genetics, mechanisms of disease, drug development, gene therapy and gene
editing updates, stem cell therapies, tools to monitor disease progression, and reports on clinical trials. These
meetings provide and ideal environment for trainees and young faculty to establish or accelerate their careers
in the field by providing exposure to leaders in the field, providing a forum for new avenues for discovery,
opportunities to develop collaborations, and will serve to encourage investigators to translate new findings into
novel therapies.

## Key facts

- **NIH application ID:** 10364600
- **Project number:** 5R13EY022574-08
- **Recipient organization:** UNIVERSITY OF FLORIDA
- **Principal Investigator:** John D Ash
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1
- **Award type:** 5
- **Project period:** 2012-06-21 → 2022-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10364600

## Citation

> US National Institutes of Health, RePORTER application 10364600, Retinal Degeneration Conference (5R13EY022574-08). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10364600. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*